Ara-290 (10 x vials)

$390.00
  • Formula: C₅₁H₈₄N₁₆O₂₁

  • Molecular Weight: ~1257 Da (1257.31 g/mol)

  • Sequence: {Glp}-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-OH (Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser)

  • Synonyms: Cibinetide, EPO-derived peptide 

Key Functions & Effects

  • Activates Innate Repair Receptor (IRR):

    It binds to the IRR (a complex of EPO receptor and CD131) to trigger tissue protection. 

  • Reduces Neuropathic Pain:

    Effectively alleviates pain in nerve damage, even targeting TRPV1 channels, and suppresses spinal inflammation. 

  • Improves Metabolic Control:

    Shows benefits in Type 2 Diabetes by improving HbA1c and lipid profiles. 

  • Promotes Nerve Repair:

    Increases corneal nerve fiber density (CNFD) in some diabetic patients, indicating nerve regeneration. 

  • Non-Hematopoietic:

    Unlike EPO, it doesn't stimulate red blood cell production, avoiding associated side effects like hypertension. 

How it Works

ARA 290 separates the beneficial, tissue-protective functions of EPO from its hematopoietic (blood-building) effects by selectively activating the IRR, leading to anti-inflammatory and regenerative signals. 

  • Formula: C₅₁H₈₄N₁₆O₂₁

  • Molecular Weight: ~1257 Da (1257.31 g/mol)

  • Sequence: {Glp}-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-OH (Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser)

  • Synonyms: Cibinetide, EPO-derived peptide 

Key Functions & Effects

  • Activates Innate Repair Receptor (IRR):

    It binds to the IRR (a complex of EPO receptor and CD131) to trigger tissue protection. 

  • Reduces Neuropathic Pain:

    Effectively alleviates pain in nerve damage, even targeting TRPV1 channels, and suppresses spinal inflammation. 

  • Improves Metabolic Control:

    Shows benefits in Type 2 Diabetes by improving HbA1c and lipid profiles. 

  • Promotes Nerve Repair:

    Increases corneal nerve fiber density (CNFD) in some diabetic patients, indicating nerve regeneration. 

  • Non-Hematopoietic:

    Unlike EPO, it doesn't stimulate red blood cell production, avoiding associated side effects like hypertension. 

How it Works

ARA 290 separates the beneficial, tissue-protective functions of EPO from its hematopoietic (blood-building) effects by selectively activating the IRR, leading to anti-inflammatory and regenerative signals. 

For laboratory research use only.

Not intended for human consumption or therapeutic use.

Handling by trained research professionals is required.